| 臺大學術典藏 |
2020-04-10T12:15:56Z |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Lu L.-C.;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Yu-Yun Shao;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; YU-YUN SHAO; Liu T.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Liu T.-H.;Yu-Yun Shao;Lu L.-C.;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; YU-YUN SHAO; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Potent activity of composite cyclin dependent kinase inhibition against hepatocellular carcinoma
|
Yu-Yun Shao;Li Y.-S.;Hsu H.-W.;Lin H.;Wang H.-Y.;Wo R.R.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Li Y.-S.; Hsu H.-W.; Lin H.; Wang H.-Y.; Wo R.R.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.;Lin C.-C.;Lin C.-Y.;Hsieh M.-S.;Kuo H.-Y.;Lien M.-Y.;Yu-Yun Shao;Huang T.-C.;Hsu C.-H.; Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; YU-YUN SHAO; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-10T12:15:53Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Yu-Yun Shao;Liu T.-H.;Hsu C.;Lu L.-C.;Shen Y.-C.;Lin Z.-Z.;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2020-04-09T09:42:28Z |
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials
|
Shao, Y.-Y.; Shau, W.-Y.; Chan, S.-Y.; Lu, L.-C.; Hsu, C.-H.; Cheng, A.-L. |
| 臺大學術典藏 |
2020-04-09T09:39:09Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao, Y. Y.; Chen, B. B.; Ou, D. L.; Lin, Z. Z.; Hsu, C. H.; Wang, M. J.; Cheng, A. L.; Hsu, C. |
| 臺大學術典藏 |
2020-04-09T09:31:03Z |
Key opioid prescription concerns in cancer patients: A nationwide study
|
Shao, Y. Y.; Lin, C. P.; Hsu, C. H.; Fu, W. M.; Chen, H. M.; Lee, Y. H.; Lai, M. S. |
| 臺大學術典藏 |
2020-04-08T02:10:16Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Hsiao M.-Y.;Lin A.-C.;Liao W.-H.;Tyng-Guey Wang;Hsu C.-H.;Chen W.-S.;Lin F.-H.; Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; TYNG-GUEY WANG; Hsu C.-H.; Chen W.-S.; Lin F.-H. |
| 臺大學術典藏 |
2020-04-08T01:10:30Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Yu, S.-L.; Yang, T.-Y.; Chang, G.-C.; Chang, G.-C.;Yang, T.-Y.;Yu, S.-L.;Chen, H.-W.;Chen, J.J.W.;Su, K.-Y.;Hsu, C.-H.;Chen, K.-C.;Tseng, J.-S.;Hsu, K.-H.;Huang, Y.-H.; Huang, Y.-H.; Hsu, K.-H.; Tseng, J.-S.; Chen, K.-C.; Hsu, C.-H.; Su, K.-Y.; Chen, J.J.W.; Chen, H.-W. |
| 臺大學術典藏 |
2020-04-07T13:17:43Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; TYNG-GUEY WANG; Hsu C.-H.; Chen W.-S.; Lin F.-H. |
| 臺大學術典藏 |
2020-04-07T13:15:18Z |
The effect of the repression of oxidative stress on tenocyte differentiation: A preliminary study of a rat cell model using a novel differential tensile strain bioreactor
|
Liu L.; Lin F.-H.; Iafisco M.; Gefen A.; Wu Y.-W.; He C.-K.; Hsu C.-H.; Ming-Yen Hsiao;Lin P.-C.;Liao W.-H.;Chen W.-S.;Hsu C.-H.;He C.-K.;Wu Y.-W.;Gefen A.;Iafisco M.;Liu L.;Lin F.-H.; MING-YEN HSIAO; Lin P.-C.; Liao W.-H.; Chen W.-S. |
| 臺大學術典藏 |
2020-04-07T07:54:50Z |
Family-centered care improved neonatal medical and neurobehavioral outcomes in preterm infants: Randomized controlled trial
|
Yu Y.-T.; Hsieh W.-S.; Hsu C.-H.; Lin Y.-J.; Lin C.-H.; Hsieh S.; LU LU; Cherng R.-J.; Chang Y.-J.; Fan P.-C.; Yao N.-J.; Chen W.J.; Jeng S.-F. |
| 臺大學術典藏 |
2020-03-31T03:59:41Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.;Lin C.-C.;Jang-Ming Lee;Chang Y.-L.;Hsu C.-H.;Tsai Y.-C.;Lee Y.-C.;Cheng J.C.-H.; Hsu F.-M.; Lin C.-C.; JANG-MING LEE; Chang Y.-L.; Hsu C.-H.; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:39Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Cheng J.C.-H.; Tsai Y.-C.; Wu J.-K.; Lin C.-C.; Hsu C.-H.; JANG-MING LEE; Lee Y.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:34Z |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Chang Y.-L.; Wang H.-P.; Hsu C.-H.; JANG-MING LEE; Cheng M.-F.; Yen R.-F.; Wu Y.-W.; Chung C.-S.; Yen T.-J. |
| 臺大學術典藏 |
2020-03-31T03:59:26Z |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Hsu C.-H.; Koong A.C.; Chang D.T.; Chia-Hsien Cheng J.; Huang P.-M.; JANG-MING LEE; Tsai C.-L.; Wu J.-K.; Lu S.-L.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:26Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; Chang Y.-L.; Hsu F.-M. |
| 臺大學術典藏 |
2020-03-31T03:59:24Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Yeh K.-H.; Cheng A.-L.; Wang H.-P.; Cheng J.C.-H.; Hsu F.-M.; JANG-MING LEE; Huang P.-M.; Chang C.-H.; Lin C.-C.; Hsieh M.-S.; Guo J.-C.; Huang T.-C. |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Yeh K.-H.;Hsu C.-H.;Jang-Ming Lee; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:16Z |
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
|
Huang P.-M.;Hsu F.-M.;Lin C.-C.;Hsu C.-H.;Cheng J.C.-H.;Jang-Ming Lee; Huang P.-M.; Hsu F.-M.; Lin C.-C.; Hsu C.-H.; Cheng J.C.-H.; JANG-MING LEE |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Jang-Ming Lee;Huang P.-M.;Hsu C.-H.;Lin C.-C.;Chang Y.-L.;Hsieh M.-S.;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L.; JANG-MING LEE; Huang P.-M.; Hsu C.-H.; Lin C.-C.; Chang Y.-L.; Hsieh M.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-03-31T03:59:14Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; JANG-MING LEE; Wang H.-P.; Chia-Hsien Cheng J.; Wu Y.-C.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Jang-Ming Lee;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2020-03-30T13:03:15Z |
Drug-loaded hyaluronic acid hydrogel as a sustained-release regimen with dual effects in early intervention of tendinopathy
|
Lin F.-H.; WEN-SHIANG CHEN; Hsiao M.-Y.;Lin A.-C.;Liao W.-H.;Wang T.-G.;Hsu C.-H.;Wen-Shiang Chen;Lin F.-H.; Hsiao M.-Y.; Lin A.-C.; Liao W.-H.; Wang T.-G.; Hsu C.-H. |
